Jul 16, 2026
Eli Lilly (LLY) Stock Dips Following $2.8B AtaiBeckley Acquisition for Depression Treatment Pipeline
Eli Lilly (LLY) stock declined after unveiling a $2.8B AtaiBeckley acquisition, adding late-stage depression treatments including FDA breakthrough therapy BPL-003.
The post Eli Lilly (LLY) Stock Dips Following $2.8B AtaiBeckley Acquisition for Depression Treatment Pipeline appeared first on Blockonomi.
Source: Blockonomi →Related News
- 1 hour ago
Paramount Skydance (PSKY) Stock: Surges as Debt Offers Extend to August 21 Befor...
- 1 hour ago
Sharplink Inc. (SBET) Stock: Surges as $125M Galaxy Fund Expands Ethereum Treasu...
- 2 hours ago
SEALSQ Corp (LAES) Stock Climbs on $200M Quantum Technology Initiative Progress
- 4 hours ago
SpaceX (SPCX) Stock: Expands AI Cloud Business With $20.8 Billion in New Contrac...
- 4 hours ago
SanDisk (SNDK) Stock Rebounds in Premarket Despite Post-Earnings Volatility